vs

Side-by-side financial comparison of BLACKLINE, INC. (BL) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $183.2M, roughly 1.8× BLACKLINE, INC.). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs 2.7%, a 1.4% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs 2.2%).

BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

BL vs GRDN — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.8× larger
GRDN
$336.6M
$183.2M
BL
Growing faster (revenue YoY)
BL
BL
+5.9% gap
BL
8.1%
2.2%
GRDN
Higher net margin
GRDN
GRDN
1.4% more per $
GRDN
4.0%
2.7%
BL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BL
BL
GRDN
GRDN
Revenue
$183.2M
$336.6M
Net Profit
$4.9M
$13.5M
Gross Margin
75.2%
22.7%
Operating Margin
3.7%
5.3%
Net Margin
2.7%
4.0%
Revenue YoY
8.1%
2.2%
Net Profit YoY
-91.3%
46.1%
EPS (diluted)
$0.07
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BL
BL
GRDN
GRDN
Q1 26
$336.6M
Q4 25
$183.2M
$397.6M
Q3 25
$178.3M
$377.4M
Q2 25
$172.0M
$344.3M
Q1 25
$166.9M
$329.3M
Q4 24
$169.5M
Q3 24
$165.9M
$314.4M
Q2 24
$160.5M
Net Profit
BL
BL
GRDN
GRDN
Q1 26
$13.5M
Q4 25
$4.9M
$20.9M
Q3 25
$5.3M
$9.8M
Q2 25
$8.3M
$9.0M
Q1 25
$6.1M
$9.4M
Q4 24
$56.4M
Q3 24
$17.2M
$-122.0M
Q2 24
$76.7M
Gross Margin
BL
BL
GRDN
GRDN
Q1 26
22.7%
Q4 25
75.2%
21.5%
Q3 25
75.1%
19.8%
Q2 25
75.2%
19.8%
Q1 25
75.5%
19.5%
Q4 24
75.6%
Q3 24
75.2%
19.4%
Q2 24
74.9%
Operating Margin
BL
BL
GRDN
GRDN
Q1 26
5.3%
Q4 25
3.7%
7.7%
Q3 25
4.3%
4.3%
Q2 25
4.4%
3.7%
Q1 25
2.1%
3.9%
Q4 24
3.7%
Q3 24
5.0%
-33.3%
Q2 24
1.4%
Net Margin
BL
BL
GRDN
GRDN
Q1 26
4.0%
Q4 25
2.7%
5.3%
Q3 25
3.0%
2.6%
Q2 25
4.8%
2.6%
Q1 25
3.6%
2.9%
Q4 24
33.3%
Q3 24
10.4%
-38.8%
Q2 24
47.8%
EPS (diluted)
BL
BL
GRDN
GRDN
Q1 26
$0.21
Q4 25
$0.07
Q3 25
$0.09
Q2 25
$0.13
Q1 25
$0.10
Q4 24
$0.79
Q3 24
$0.27
Q2 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BL
BL
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$390.0M
$64.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$332.3M
$232.4M
Total Assets
$1.8B
$426.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BL
BL
GRDN
GRDN
Q1 26
$64.9M
Q4 25
$390.0M
$65.6M
Q3 25
$419.9M
$36.5M
Q2 25
$459.1M
$18.8M
Q1 25
$479.5M
$14.0M
Q4 24
$885.9M
Q3 24
$725.3M
$37.2M
Q2 24
$616.6M
Total Debt
BL
BL
GRDN
GRDN
Q1 26
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$34.3M
Q2 24
Stockholders' Equity
BL
BL
GRDN
GRDN
Q1 26
$232.4M
Q4 25
$332.3M
$217.9M
Q3 25
$328.3M
$195.5M
Q2 25
$414.0M
$179.7M
Q1 25
$417.9M
$163.2M
Q4 24
$446.7M
Q3 24
$367.9M
$133.9M
Q2 24
$325.8M
Total Assets
BL
BL
GRDN
GRDN
Q1 26
$426.9M
Q4 25
$1.8B
$412.7M
Q3 25
$1.7B
$390.0M
Q2 25
$1.8B
$356.3M
Q1 25
$1.8B
$334.0M
Q4 24
$1.8B
Q3 24
$1.7B
$348.0M
Q2 24
$1.9B
Debt / Equity
BL
BL
GRDN
GRDN
Q1 26
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.26×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BL
BL
GRDN
GRDN
Operating Cash FlowLast quarter
$26.7M
$6.1M
Free Cash FlowOCF − Capex
$26.1M
FCF MarginFCF / Revenue
14.2%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
5.46×
0.45×
TTM Free Cash FlowTrailing 4 quarters
$161.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BL
BL
GRDN
GRDN
Q1 26
$6.1M
Q4 25
$26.7M
$34.6M
Q3 25
$63.8M
$28.2M
Q2 25
$32.3M
$19.9M
Q1 25
$46.7M
$17.6M
Q4 24
$43.8M
Q3 24
$55.9M
Q2 24
$40.7M
Free Cash Flow
BL
BL
GRDN
GRDN
Q1 26
Q4 25
$26.1M
Q3 25
$63.3M
$24.2M
Q2 25
$31.4M
Q1 25
$40.8M
Q4 24
$43.0M
Q3 24
$55.5M
Q2 24
$40.0M
FCF Margin
BL
BL
GRDN
GRDN
Q1 26
Q4 25
14.2%
Q3 25
35.5%
6.4%
Q2 25
18.2%
Q1 25
24.4%
Q4 24
25.4%
Q3 24
33.5%
Q2 24
24.9%
Capex Intensity
BL
BL
GRDN
GRDN
Q1 26
Q4 25
0.3%
Q3 25
0.3%
1.1%
Q2 25
0.6%
Q1 25
3.6%
Q4 24
0.4%
Q3 24
0.2%
Q2 24
0.4%
Cash Conversion
BL
BL
GRDN
GRDN
Q1 26
0.45×
Q4 25
5.46×
1.65×
Q3 25
12.07×
2.87×
Q2 25
3.90×
2.21×
Q1 25
7.72×
1.86×
Q4 24
0.78×
Q3 24
3.24×
Q2 24
0.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BL
BL

Subscription And Circulation$173.2M95%
Technology Service$10.0M5%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons